Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast

British Journal of Cancer

Volumn 105, Issue 5, 2011, Pages 698-708

  Hasebe, T ^a   Iwasaki, M ^b   Akashi Tanaka, S ^c   Hojo, T ^c   Shibata, T ^d   Sasajima, Y ^c   Kinoshita, T ^c   Tsuda, H ^c  

^a Center for Cancer Control and Information Services   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

blood vessel; invasive ductal carcinoma; lymph node; lymph vessel; Nottingham Prognostic Index; prognosis

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGED; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER STAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NOTTINGHAM PROGNOSTIC INDEX; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PVN CLASSIFICATION; RATING SCALE; REVIEW; TUMOR RECURRENCE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, VASCULAR TISSUE; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 80052029135     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.279     Document Type: Review

References (23)

1. Baak JP, Colpaert CG, van Diest PJ, Janssen E, van Diermen B, Albernaz E, Vermeulen PB, Van Marck EA (2005) Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers. Eur J Cancer 41: 2093-2101 (Pubitemid 41337951)
2. Blamey RW, Ellis IO, Pinder SE, Lee AHS, Macmillan RD, Morgan DAL, Robertson JFR, Mitchell MJ, Ball GR, Haybittle JL, Elston CW (2007) Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer 43: 1548-1555 (Pubitemid 46901016)
3. Colpaert C, Vermeulen PB, van Beest P, Goovaerts G, Weyler J, Van Dam P, Dirix L, Van Marck E (2001) Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients. Histopathology 39: 416-425 (Pubitemid 32990095)
4. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-4l0
5. Gilchrist KW, Gray R, Fowble B, Fowble B, Tormey DC, Taylor SG (1993) Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 eastern cooperative oncology group patients. J Clin Oncol 11: 1929-1935 (Pubitemid 23304618)
6. Harvey JM, Clark GM, Osborne K, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474-1481 (Pubitemid 29220854)
7. Hasebe T, Iwasaki M, Akashi-Tanaka S, Hojo T, Shibata T, Sasajima Y, Tsuda H, Kinoshita T (2011) Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes. Hum Pathol; e-pub ahead of print 17 June 2011
8. Hasebe T, Okada N, Iwasaki M, Akashi-Tanaka S, Hojo T, Shibata T, Sasajima Y, Tsuda H, Kinoshita T (2010) Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast. Hum Pathol 41: 706-715
9. Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A (2002a) Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 15: 502-516 (Pubitemid 34521399)
10. Hasebe T, Sasaki S, Imoto S, Ochiai A (2003a) Histological characteristics of tumors in blood vessels play an important role in tumor progression of invasive ductal carcinoma of the breast. Cancer Sci 94: 158-165 (Pubitemid 36575875)
11. Hasebe T, Sasaki S, Imoto S, Ochiai A (2003b) Significance of nodal metastatic tumor characteristics in nodal metastasis and prognosis of patients with invasive ductal carcinoma of the breast. Cancer Sci 94: 181-187 (Pubitemid 36575878)
12. Hasebe T, Sasaki S, Imoto S, Ochiai A (2004) Histological characteristics of tumors in vessels and lymph nodes are significant parameter for predicting tumor progression of invasive ductal carcinoma of the breast: a prospective study. Hum Pathol 35: 298-308 (Pubitemid 38339603)
13. Hasebe T, Sasaki S, Imoto S, Ochiai A (2002b) Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study. Mod Pathol 15: 904-913
14. Hasebe T, Sasaki S, Imoto S, Wada N, Ochiai A (2005) Primary tumor-vessel tumor-nodal tumor classification for patients with invasive ductal carcinoma of the breast. Br J Cancer 92: 847-856 (Pubitemid 40462629)
15. Hasebe T, Tsuda H, Hirohashi S, Shimosato Y, Tsubono Y, Yamamoto H, Mukai K (1998) Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat 49: 195-208 (Pubitemid 28416785)
16. Hasebe T, Yamauchi C, Iwasaki M, Ishii G, Wada N, Imoto S (2008) Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast. Hum Pathol 39: 427-436 (Pubitemid 351193070)
17. Hasebe T, Okada N, Tamura N, Houjoh T, Akashi-Tanaka S, Tsuda H, Shibata T, Sasajima Y, Iwasaki M, Kinoshita T (2009) p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast. Cancer Sci 100: 2101-2108
18. Mohsin S, Weiss H, Havighurst T, Clark GM, Berardo M, Roanh le D, To TV, Qian Z, Love RR, Allred DC (2004) Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol 17: 1545-1554 (Pubitemid 39627082)
19. Sobin LH, Gospodarowicz MK, Wittekind Ch (eds). (2009) International Union Against Cancer TNM Classification of Malignant Tumours, 7th edn, pp 181-193. Wiley-Liss: Geneva
20. Sobin LH, Wittekind Ch (eds). (2002) International Union Against Cancer TNM Classification of Malignant Tumors, 6th edn, pp 131-141. Wiley-Liss: Geneva
21. Sundquist M, Thorstenson S, Brudin L, Nordenskjold B (1999) Applying the Nottingham Prognostic Index to a Swedish breast cancer population. Breast Cancer Res Treat 53: 1-8 (Pubitemid 29123614)
22. Todd JH, Dowle C, Williams MR, Elston CW, Ellis O, Hinton CP, Blamey RW, Haybittle JL (1987) Confirmation of a prognostic index in primary breast cancer. Br J Cancer 56: 489-492 (Pubitemid 17146357)
23. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF, American Society of Clinical Oncolgy/College of American Pathologists (2007) American Scociety of Clinical Oncology/College of American Patholo-gists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131: 18-43 (Pubitemid 46174133)